Protocol No.: HQP1351AG301
- Title
- A Global Multicenter, Open Label, Randomized Phase 3 Registrational Study of Olverembatinib Combined with Chemotherapy Versus Investigator s Choice of TKI Combined with Chemotherapy in Patients with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ ALL) (POLARIS-1)
- Principal Investigator
- Emadi, Ashkan
- Phase
- III (Cancer Control)
- Age Group
- Adult
- Applicable Disease Site
- Leukemia
- Participating Institution
- Mary Babb Randolph Cancer Center
- Contact
- Caitlin Slack, BS
- Clinical Research Coordinator
- Email: caitlin.slack@hsc.wvu.edu